Company data sheet · Neurocrine Biosciences
Neurocrine Biosciences: growth far beyond its economy.
- Industry
- Biological Products,
- Headquarters
- United States
- Ticker
- NBIX (Nasdaq)
- Sources
- SEC filings (1996–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
- Data as of
- October 18, 2026
- From profit to five straight losses. Neurocrine Biosciences lost money every year from 2013 to 2017: $0.5 billion in all. 2018 was its first profit in six years: $0 billion.
- It outgrew its own economy many times over. Revenue rose from $0 billion in 2016 to $2.9 billion in 2025: 190.7 times as much. The US economy, counted the same way in money terms, grew about 60%. Whatever drove it, the economy around it does not account for growth of that size.
- Ahead of almost everyone like it. From 2016 to 2025, its revenue grew 18973% in US dollars; the median among 586 large manufacturers grew 58%. It outgrew 99% of them.
- Leaders came and went. Neurocrine Biosciences filed 32 leadership changes since 2016, more than 83% of large manufacturers (the median is 19). The day after each, its shares moved a median 0.3 points against its sector. The news was rarely news.
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2016 | $0 billion | −$0.1 billion | |
| 2017 | $0.2 billion | −$0.1 billion | |
| 2018 | $0.5 billion | $0 billion | |
| 2019 | $0.8 billion | $0 billion | |
| 2020 | $1 billion | $0.4 billion | |
| 2021 | $1.1 billion | $0.1 billion | |
| 2022 | $1.5 billion | $0.2 billion | |
| 2023 | $1.9 billion | $0.2 billion | |
| 2024 | $2.4 billion | $0.3 billion | |
| 2025 | $2.9 billion | $0.5 billion |
As reported in its annual filings. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Market reaction to disclosed decisions: 47 decision filings since 2016, each linked to the SEC, with the share return against its sector and the S&P 500 the next day and the next year (33 with market data).
- Economic context: 7 measures for the United States, every year since 2016, from the official sources.
- Peer comparison: against 953 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.